Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 05 - 04 source : Www.biospace.com save search
Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results
Published: 2022-05-04 (Crawled : 21:00) - biospace.com/
ACAD | $16.82 -1.47% -1.49% 3.5M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: -0.3%
results
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results
Published: 2022-05-04 (Crawled : 21:00) - biospace.com/
DMAC | $2.46 -1.21% -1.22% 21K
|
Health Technology
|
| O: 2.29%
H: 1.12%
C: -7.46%
therapeutics results
Athira Investor Calls For Former GSK Exec to Take Reigns
Published: 2022-05-04 (Crawled : 19:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 1.29%
H: 0.33%
C: -2.46%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 0.0%
H: 2.48%
C: 2.48%
Conformis Reports First Quarter 2022 Financial Results
Published: 2022-05-04 (Crawled : 18:00) - biospace.com/
CFMS | $2.26 0.44% 0
|
Health Technology
|
| O: 5.15%
H: 0.57%
C: -4.48%
results
Achilles Therapeutics Appoints Bernhard Ehmer to Board of Directors
Published: 2022-05-04 (Crawled : 17:00) - biospace.com/
ACHL | $0.7827 -2.16% -2.21% 200K
|
Manufacturing
|
| O: 2.15%
H: 1.89%
C: -1.68%
therapeutics
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
Published: 2022-05-04 (Crawled : 17:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: -1.2%
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.48%
H: 1.8%
C: -4.96%
agtc-501 ongoing research positive phase 1
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
Published: 2022-05-04 (Crawled : 16:00) - biospace.com/
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 1.65%
H: 3.78%
C: 3.24%
Sagimet Biosciences to Present Additional Biomarker Phase 2 Data on Denifanstat (TVB-2640) in NASH Patients at DDW 2022
Published: 2022-05-04 (Crawled : 16:00) - biospace.com/
SGMT | $4.0 0.76% 0.75% 430K
|
Health Technology
| Email alert
Add to watchlist
tvb-2640 nash biomarkers phase 2
Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
STVN | $26.73 -5.88% 0.0% 670K
|
|
| O: 0.19%
H: 3.61%
C: 2.15%
aidaptus collaboration group
Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
ANVS | $10.09 2.44% -0.15% 220K
|
Health Technology
|
| O: 2.34%
H: 12.21%
C: 11.45%
results
Regeneron Overcomes Loss of COVID Antibody to Post Positive First Quarter
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.68%
H: 0.0%
C: 0.0%
covid antibody positive
Marker Therapeutics to Present Four Posters on its T Cell-Based Immunotherapies at the 2022 International Society for Cell & Gene Therapy Annual Meeting
Published: 2022-05-04 (Crawled : 15:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: 1.0%
H: 8.8%
C: 6.93%
therapeutics therapy international
Minerva Neurosciences Reports First Quarter 2022 Financial Results and Business UpdatesCompany Expects to Submit an NDA for Roluperidone, Subject to FDA Guidance, in the Third Quarter of 2022
Published: 2022-05-04 (Crawled : 14:00) - biospace.com/
NERV | $2.5 1.2% 11K
|
Health Technology
|
| O: 0.0%
H: 3.79%
C: -0.2%
fda
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma
Published: 2022-05-04 (Crawled : 14:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.81%
H: 2.0%
C: 1.57%
treatment pharma antibody trial therapy nivolumab
Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 2.19%
H: 3.08%
C: 2.37%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: 0.21%
H: 4.59%
C: 3.64%
cancer breast cancer
RAPT Therapeutics Expands Leadership Team with Multiple Key Hires
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
RAPT | $7.96 0.38% 0.38% 790K
|
Health Technology
|
| O: -1.12%
H: 0.2%
C: -0.6%
FGEN | $1.15 -1.71% -1.74% 1.3M
|
Health Technology
|
| O: 0.31%
H: 0.21%
C: -0.62%
therapeutics
Tivic Health to Report First Quarter 2022 Earnings on May 16th Via Conference Call and Webcast
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
TIVC | $1.157 -0.45% 15K
|
|
| O: -2.5%
H: 12.18%
C: 8.97%
conference report health
Hologic to Webcast Presentation at Upcoming Investor Conference
Published: 2022-05-04 (Crawled : 13:20) - biospace.com/
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
|
| O: 0.25%
H: 3.53%
C: 3.26%
conference presentation
IN8bio to Present at May Investor and Scientific Conferences
Published: 2022-05-04 (Crawled : 13:00) - biospace.com/
INAB | $1.0 -4.76% -5.0% 280K
|
|
| O: 10.0%
H: 0.0%
C: -1.09%
Enteris BioPharma to Exhibit at CPhI North America 2022
Published: 2022-05-04 (Crawled : 13:00) - biospace.com/
SWKH | $17.52 1.04% 1.03% 7.7K
|
Miscellaneous
|
| O: -0.92%
H: 0.93%
C: 0.21%
america biopharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.